TRDN and catecholaminergic polymorphic ventricular tachycardia: CPVT-related mutations have been associated with mutations affecting the cardiac ryanodine receptor (RYR2), calsequestrin (CASQ2), triadin (TRDN) and calmodulin (CALM1 and CALM2) genes [1].